Martin Shkreli, also known as “Pharma Bro,” recently shared his short positions on Bitcoin, MicroStrategy, and several quantum computing stocks. Despite his controversial past, Shkreli’s knack for reading markets cannot be ignored. He argues that these assets have shown signs of overvaluation and are due for a correction.
However, his contrarian approach carries significant risk, and investors should exercise caution when making decisions based on his predictions.
Source